Today: 27 June 2026
Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results
21 February 2026
2 mins read

Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results

NEW YORK, Feb 21, 2026, 14:53 EST — Market has closed.

  • Salesforce closed out Friday at $185.16, barely budging after a volatile week.
  • Citi and BMO trimmed their price targets, citing some early deal activity but noting the signals on AI product uptake remain mixed.
  • GoDaddy’s partnership with Salesforce’s MuleSoft division brought renewed attention to AI “agent” security just before earnings.

Salesforce, Inc. shares barely budged Friday, with investors weighing a batch of new price-target cuts just before the company posts quarterly results next week.

Why this matters: Shares are trading close to recent lows, and Salesforce’s upcoming earnings could give a clearer sense of enterprise software appetite in the near term. Traders are zeroed in on whether the company’s AI initiatives can actually drive more consistent growth. Investing.com

It’s an awkward set-up. Bulls argue there are big wins with major customers and emphasize tighter cost control. Bears, though, are keyed in on the sluggish sales cycle and remain skeptical about how fast the new “agent” tools are actually driving paid usage instead of just more demos. Investing.com

Citigroup cut its price target to $197 from $257 while maintaining a Neutral rating. Analysts described their stance as “tactically positive” ahead of the quarter, citing fieldwork that pointed to “accelerated large deal activity.” Still, Citi noted “underwhelming” Agentforce usage as a ceiling on further gains. TipRanks

BMO Capital lowered its price target on the stock to $235 from $275, sticking with an Outperform but flagging “modest” uptake for Agentforce and Data Cloud and what it described as lackluster upsell rates. The firm doesn’t see the quarterly report shifting long-held bull or bear positions. Investing.com

Shares of Salesforce ended Friday at $185.16, slipping about 3% from Tuesday’s close according to recent settlement data. The stock moved in a range from roughly $184 to $192 during the session. Investing.com

GoDaddy announced Feb. 19 it’s linking its Agent Name Service to Salesforce’s MuleSoft Agent Fabric. The move is meant to make it easier for customers to find and authenticate AI agents, as more firms deploy automated software “agents” throughout their organizations. GoDaddy

Travis Muhlestein, GoDaddy’s chief technology officer of product and AI, put it this way in the release: “The agentic ecosystem on the open internet is exploding, so trust and identity need to keep up.” Salesforce’s Andrew Comstock, who heads MuleSoft as SVP and general manager, called the integration a “digital passport” designed to rein in “agent sprawl.” GoDaddy

Announcements like these have turned into a kind of barometer for how investors judge Salesforce’s AI ambitions. Agentforce, shorthand for software “agents” that execute tasks with minimal human direction, sits at the center of the discussion. The key question: can these tools drive enough of a bump in renewal and expansion to move the needle on bookings and deferred revenue? Investing.com

But there’s risk on the table. Should next week’s guidance come off as cautious—or if buyers stick to evaluating AI add-ons without stepping up spending—the stock could slide toward its recent lows. That’s especially in play as rivals roll out their own automation tools.

Investors are now looking to Salesforce’s fiscal 2026 fourth-quarter and full-year numbers, expected after the bell on Feb. 25. The company’s conference call will follow later that day. Salesforce Investor Relations

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Latest Stock Market News

IPO calendar eyes Bending Spoons as shortened week thins deal pipeline

IPO calendar eyes Bending Spoons as shortened week thins deal pipeline

27 June 2026
Bending Spoons (NASDAQ:BSP) drives 61% of next week’s $2.56 billion U.S. IPO proceeds, making its $1.57 billion raise a key test for investor appetite in debt-heavy software M&A, with a $18.1 billion valuation and 4.0x net debt to EBITDA leverage, as markets brace for a holiday-shortened week and a looming $29.4 billion SK hynix Nasdaq ADR.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 27.06.2026

27 June 2026
LIVEMarkets rolling coverageStarted: June 27, 2026, 4:00 AM EDTUpdated: June 27, 2026, 7:00 AM EDT Marks and Spencer Fair Value Rises to £4.31 Amid Mixed Analyst Outlooks June 27, 2026, 6:52 AM EDT. Marks and Spencer Group’s fair value estimate edged up slightly to £4.31 from £4.27 following recent analyst revisions. Morgan Stanley and Bernstein initiated coverage with bullish ratings and price targets near £4.40, citing recovery potential in the UK food retail sector despite competition from Tesco and Sainsbury. Conversely, Citi cut its price target to £3.90, reflecting cautious views on execution risks. The updated valuation includes a marginal
Joby Aviation (NYSE:JOBY) drops as Russell rebalance brings volume spike

Joby Aviation (NYSE:JOBY) drops as Russell rebalance brings volume spike

27 June 2026
Nearly 40% of Joby’s public float traded hands in five sessions as the stock slid 10.45% into the Russell index rebalance, with Friday’s $496 million turnover equal to 6% of market value; volume surge and 16% short interest signal volatile positioning, while the stock closed 25% below a recent insider sale.
GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines
Previous Story

GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop